CHIT1 and amyotrophic lateral sclerosis: Our study demonstrates CHIT-1 not only as an early diagnostic biomarker for ALS, but also as a key molecule for therapeutic intervention targeting neuroinflammation at the early stages of this crippling and fatal neurodegenerative disorder.